Advertisement

Topics

Gendel Limited Company Profile

19:32 EDT 20th September 2017 | BioPortfolio

Gendel is an innovative life sciences company formed in December 1998 to develop a drug delivery technology based on red cell sensitisation followed by the application of ultrasound. The company has made outstanding progress in the advancement of this platform technology.

Exploiting the novel concepts and technology conceived by Professor Tony McHale at the University of Ulster, the Gendel localised drug delivery system uses "loaded" and "sensitised" red blood cells to transport drugs around the body. These drugs can then be released at localised sites by the application of non-invasive low intensity ultrasound.

Location

Science Innovatin Centre, Science Research Park, Cromore Road
Coleraine
Northern Ireland
BT52 1ST
United Kingdom

Contact

Phone: 028 70 28 00 22
Fax: 028 70 28 00 97
Email: gendel@ulst.ac.uk


News Articles [14 Associated News Articles listed on BioPortfolio]

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference

JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

Gendel Limited

Gendel is an innovative life sciences company formed in December 1998 to develop a drug delivery technology based on red cell sensitisation followed by the application of ultrasound. The company has m...

Gendal Limited

Gendel Limited is developing a safe novel medical device technologu for the treatment of solod cancer tumours in the absence of any drug

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Gendel Limited" on BioPortfolio

We have published hundreds of Gendel Limited news stories on BioPortfolio along with dozens of Gendel Limited Clinical Trials and PubMed Articles about Gendel Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gendel Limited Companies in our database. You can also find out about relevant Gendel Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Radiology
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...


Corporate Database Quicklinks



Searches Linking to this Company Record